Open | $0.390 |
Close | $0.386 |
Volume / Avg. | 119.817K / 391.544K |
Day Range | 0.386 - 0.409 |
52 Wk Range | 0.360 - 2.920 |
Market Cap | $10.358M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 1.33% |
Days to Cover | 1.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioCardia (NASDAQ: BCDA) through any online brokerage.
Other companies in BioCardia’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for BioCardia (NASDAQ: BCDA) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a price target for 4.00 expecting BCDA to rise to within 12 months (a possible 900.75% upside). 8 analyst firms have reported ratings in the last year.
The stock price for BioCardia (NASDAQ: BCDA) is $0.3997 last updated March 18, 2024 at 5:56 PM EDT.
There are no upcoming dividends for BioCardia.
BioCardia’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for BioCardia.
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.